priority review voucher

accelerated
Favicon Fierce Biotech

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

The national priority vouchers position companies including Merck KGaA, Regeneron and Sanofi to complete the review process in one to two months.
Nick Paul Taylor Oct 17, 2025 8:30am
Man hands gold dollar sign to another man

Bavarian Nordic's $160M PRV price reflects new realities

Jun 18, 2025 11:47am
Clock in front of the subway
Favicon Fierce Biotech

FDA 'on track' to meet all PDUFA dates, Marty Makary says

Jun 18, 2025 4:00am
rare diseases
Favicon Fierce Biotech

Stealth CEO questions FDA rejection of rare disease drug

May 29, 2025 2:27pm
signing contract

Abeona nets $155M with FDA voucher sale

May 12, 2025 9:34am
zebra

Zevra lines up $150M from sale of PRV tied to Miplyffa approval

Feb 27, 2025 9:58am